Tech & Pharma
Researchers in Australia have begun human trials of a vaccine for Streptococcus A, the bacterium that causes rheumatic fever.
Researchers have designed a new drug to safeguard against epidemic and pandemic influenza virus strains.
Pfizer Inc. will conduct a clinical trial of its crizotinib drug, marketed under the trademark Xalkori®, in four Asian countries.
The Australian Federal Court has ruled that Genetic Technologies Limited may continue to hold a patent on a mutation in the BRCA1 gene.
Researchers in Australia are using 3D printing to build a new generation of hi-tech fish tags to track big fish.
Chinese scientists have developed and tested a prototype electronic notebook that can be used to convert Braille into Chinese characters automatically.
Singapore’s health regulatory agency is implementing a new drug development regulatory model to accelerate the translation of drugs into the clinic.
China and India are catching up to the world leaders in innovation and should no longer be labeled as ‘imitation nations,’ according to a study.
Actis has made a significant minority investment in Nanjing Micro-Tech, the leading producer of non-vascular stents and disposable biopsy forceps in China.
U.S.-based Stryker Corporation made an offer for Chinese orthopedic manufacturer Trauson Holdings Company Limited.